Back to Search Start Over

CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs

Authors :
Zhang, Li
Mosquera, Isabel
Lucas, Eric
Rol, Mary Luz
Carvalho, Andre L.
Basu, Partha
Sadowski, Daniel
Natasha, Bartlett
Budd, Alison
Nessa, Ashrafun
De Brabander, Isabel
Haelens, Annemie
Pringels, Sarah
Tairo, Jonas
Hofvind, Solveig
Burrion, J. B.
Valerianova, Zdravka
Tinmouth, Jill
Law, Cindy
Ebenuwah, Simbi
McCurdy, Bronwen
Janik, Beata
Pupwe, George
Groeneveld, Linn Fenna
Skare, Gry Baadstrand
Layne, Penelope
Sarkeala, Tytti
Chaila, Mwate Joseph
Kaminski, Michal
Kinel, Beata
Lissowska, Jolanta
Mumukunde, Inga
Rodrigues, Vitor
Rodríguez, Robinson
Sanz, Elena Pérez
Alberdi, Raquel Zubizarreta
Ronco, Guglielmo
Antoljak, Nataša
Nakić, Dinka
Plazanin, Davor
Parun, Andrea Šupe
Goossens, Mat
Nowakowski, Andrzej
de Koning, Harry
Dams, Els
Martin, Asha
Epermane, Mara
Fracheboud, Jacques
Toes-Zoutendijk, Esther
van Agt, Heleen M.E.
Public Health
Source :
Nature Medicine, 29(5), 1135-1145. Nature Publishing Group
Publication Year :
2023

Abstract

The CanScreen5 project is a global cancer screening data repository that aims to report the status and performance of breast, cervical and colorectal cancer screening programs using a harmonized set of criteria and indicators. Data collected mainly from the Ministry of Health in each country underwent quality validation and ultimately became publicly available through a Web-based portal. Until September 2022, 84 participating countries reported data for breast (n = 57), cervical (n = 75) or colorectal (n = 51) cancer screening programs in the repository. Substantial heterogeneity was observed regarding program organization and performance. Reported screening coverage ranged from 1.7% (Bangladesh) to 85.5% (England, United Kingdom) for breast cancer, from 2.1% (Côte d’Ivoire) to 86.3% (Sweden) for cervical cancer, and from 0.6% (Hungary) to 64.5% (the Netherlands) for colorectal cancer screening programs. Large variability was observed regarding compliance to further assessment of screening programs and detection rates reported for precancers and cancers. A concern is lack of data to estimate performance indicators across the screening continuum. This underscores the need for programs to incorporate quality assurance protocols supported by robust information systems. Program organization requires improvement in resource-limited settings, where screening is likely to be resource-stratified and tailored to country-specific situations.

Details

Language :
English
ISSN :
10788956
Database :
OpenAIRE
Journal :
Nature Medicine, 29(5), 1135-1145. Nature Publishing Group
Accession number :
edsair.narcis........44ef9524de545c57b32c12c78ed3a628